# Age-Related Eye Disease Study 2 (AREDS2)

> **NCT00345176** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 4203 (actual)

## Conditions studied

- Age-related Macular Degeneration
- Cataract

## Interventions

- **DIETARY_SUPPLEMENT:** Lutein/zeaxanthin
- **DIETARY_SUPPLEMENT:** DHA/EPA
- **DRUG:** Lutein/zeaxanthin and DHA/EPA

## Key facts

- **NCT ID:** NCT00345176
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 4203 (ACTUAL)
- **Last updated:** 2015-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345176, "Age-Related Eye Disease Study 2 (AREDS2)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00345176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*